Science & Technology
Targeting macrophage maladaptation for bacterial sepsis treatment
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41AI174362-01A1
Award Ceiling
$597K
Award Floor
$597K
Close Date
May 31, 2025
Total Funding
$597K
Expected Awards
1
Posted Date
Jun 15, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-1R41AI174362-01A1
Description
STTR Phase Phase I award: "Targeting macrophage maladaptation for bacterial sepsis treatment" awarded to AcePre, LLC in Columbia, South Carolina. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $597,310. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.